Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATR | Q13535 | 3/20 | 0.41 |
| ▸ | BRD4 | O60885 | 17/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27377492 | 0.97 | ATR (0.41) | ATRBRD4 | |
| SCHEMBL30797774 | 0.90 | ATR (0.40) | ATRBRD4 | |
| SCHEMBL30797851 | 0.89 | ATR (0.43) | ATRBRD4 | |
| SCHEMBL30797730 | 0.84 | ATR (0.44) | ATRBRD4 | |
| SCHEMBL27376514 | 0.84 | ATR (0.42) | ATRBRD4 | |
| SCHEMBL30869074 | 0.83 | ATR (0.43) | ATRBRD4 | |
| SCHEMBL30869078 | 0.82 | ATR (0.45) | ATRBRD4 | |
| SCHEMBL30797873 | 0.82 | ATR (0.41) | ATRBRD4 | |
| SCHEMBL27377168 | 0.82 | ATR (0.41) | ATRBRD4 | |
| SCHEMBL30797688 | 0.81 | ATR (0.44) | ATRBRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4584249-A1 | NOVEL COMPOUNDS AS CK2 INHIBITORS | Cambridge Enterprise Limited (GB) | 2025-07-16 | — | — | EP | disclosed |
| EP-4584266-A1 | NOVEL COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES THEREOF | Cambridge Enterprise Limited (GB) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024052701-A1 | NOVEL COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES THEREOF | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2024-03-14 | — | — | WO | disclosed |
| WO-2024052702-A1 | NOVEL COMPOUNDS AS CK2 INHIBITORS | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2024-03-14 | — | — | WO | disclosed |